Product Information
CLARAVIS 30 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0993 per EA under NDC 00555105686. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555105686
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISOTRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA076135On Market Since
5/18/2006
Pharmacological Classes
Price Statistics
The NADAC for CLARAVIS 30 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 82.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0993 per EA |
|---|---|
| All-time high | $12.2436 (Oct 15, 2014) |
| All-time low | $1.8937 (Feb 18, 2026) |
| 52-week high | $2.3556 |
| 52-week low | $1.8937 |
| Median price | $5.0719 |
| Average price | $6.0237 |
| Largest weekly change | +44.9% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLARAVIS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLARAVIS 30 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.0993 per EA (NDC 00555105686), effective Jun 24, 2026.
How has the price of CLARAVIS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLARAVIS 30 MG CAPSULE has declined 82.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLARAVIS 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CLARAVIS 30 MG CAPSULE has ranged from a low of $1.8937 (Feb 18, 2026) to a high of $12.2436 (Oct 15, 2014), with a median of $5.0719 per EA.
Are there cheaper alternatives to CLARAVIS 30 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLARAVIS 30 MG CAPSULE, but none are currently priced below it.
Who manufactures CLARAVIS 30 MG CAPSULE?
CLARAVIS 30 MG CAPSULE (NDC 00555105686) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification